文献速递腹部CTMR

胰腺癌分期:可切除、交界可切除与不可切除疾病

Staging of pancreatic cancer: resectable, borderline resectable, and unresectable disease.
PubMed 文献 · Abdom Radiol (NY) · 2018-01-01

胰腺导管腺癌总体预后差,五年生存率低于10%,手术切除仍是唯一可能治愈的手段。高质量影像和图像解读对判断可切除、交界可切除或不可切除至关重要,并指导治疗规划。

要点

  • 影像用于判断胰腺癌可切除、交界可切除或不可切除。
  • 准确识别能从手术切除获益的患者至关重要。
  • 高质量影像和图像解读是分期过程的核心。

核心结论

  • 胰腺导管腺癌五年生存率低于10%,手术切除仍是唯一可能治愈的治疗,影像在判断可切除性中起核心作用。

研究设计与样本

  • 综述,未报告样本量、中心数、设备/序列及参考标准。

临床应用与阅片要点

  • 影像用于判断患者属于可切除、交界可切除或不可切除,并指导治疗规划。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Pancreatic ductal adenocarcinoma (PDAC) is a relatively common malignancy that carries an overall poor prognosis, with five-year survival below 10%. Despite ongoing research, surgical resection remains the only potentially curative treatment. Therefore, accurate identification of those patients who would benefit from surgical resection is of paramount importance. High-quality imaging and image interpretation is central to this process. Radiology helps in the determination of whether patients are resectable, borderline resectable, or unresectable and guides treatment planning.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Soloff EV, Zaheer A, Meier J, et al. Staging of pancreatic cancer: resectable, borderline resectable, and unresectable disease. Abdom Radiol (NY). 2018. PMID: 29198002. doi:10.1007/s00261-017-1410-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。